Test predicts response to treatment for complication of leukemia stem cell treatment

23 diciembre 2014

A new test may reveal which patients will respond to treatment for graft versus host disease (GVHD), an often life-threatening complication of stem cell transplants (SCT) used to treat leukemia and other blood disorders, according to a study.